Gene · 6708
Papers1,813
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,813
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evolutionary Trajectories of Primary and Metastatic Pancreatic Neuroendocrine Tumors Based on Genomic Variations. | Genes (Basel) | 2022 | 36140756 | PubTator, text mining | PubMed |
| A novel chitosan and polydopamine interlinked bioactive coating for metallic biomaterials. | J Mater Sci Mater Med | 2022 | 36138240 | PubTator, text mining | PubMed |
| Identification of a novel necroptosis-related classifier to predict prognosis and guide immunotherapy in breast invasive carcinoma. | Front Oncol | 2022 | 36132130 | PubTator, text mining | PubMed |
| A novel pyroptosis related genes signature for predicting prognosis and estimating tumor immune microenvironment in lung adenocarcinoma. | Transl Cancer Res | 2022 | 36093538 | PubTator, text mining | PubMed |
| Identifying interpretable gene-biomarker associations with functionally informed kernel-based tests in 190,000 exomes. | Nat Commun | 2022 | 36088354 | PubTator, text mining | PubMed |
| Investigation on the Fatigue Crack Propagation of Medium-Entropy Alloys with Heterogeneous Microstructures. | Materials (Basel) | 2022 | 36079462 | PubTator, text mining | PubMed |
| Literature review on genotype-phenotype correlation in patients with hereditary spherocytosis. | Clin Genet | 2022 | 36071563 | PubTator, text mining | PubMed |
| Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment. | CNS Neurosci Ther | 2022 | 36070228 | PubTator, text mining | PubMed |
| Comparison of Gene Editing versus a Neutrophil Elastase Inhibitor as Potential Therapies for ELANE Neutropenia. | J Cell Immunol | 2022 | 36052149 | PubTator, text mining | PubMed |
| Effect of primary lesions in cytoskeleton proteins on red cell membrane stability in patients with hereditary spherocytosis. | Front Physiol | 2022 | 36035481 | PubTator, text mining | PubMed |
| Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients. | Evid Based Complement Alternat Med | 2022 | 36034941 | PubTator, text mining | PubMed |
| Endofemoral Shooting Technique for Removing Well-fixed Cementless Stems. | Arthroplast Today | 2022 | 36032794 | PubTator, text mining | PubMed |
| Anesthetics and Cell-Cell Communication: Potential Ca2+-Calmodulin Role in Gap Junction Channel Gating by Heptanol, Halothane and Isoflurane. | Int J Mol Sci | 2022 | 36012286 | PubTator, text mining | PubMed |
| Analysis of Common SNPs across Continents Reveals Major Genomic Differences between Human Populations. | Genes (Basel) | 2022 | 36011383 | PubTator, text mining | PubMed |
| Integrated Analysis of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma. | Diagnostics (Basel) | 2022 | 36010268 | PubTator, text mining | PubMed |
| Integrative Multi-Omics Analysis for the Determination of Non-Muscle Invasive vs. Muscle Invasive Bladder Cancer: A Pilot Study. | Curr Oncol | 2022 | 36005168 | PubTator, text mining | PubMed |
| New KCNN4 Variants Associated With Anemia: Stomatocytosis Without Erythrocyte Dehydration. | Front Physiol | 2022 | 36003639 | PubTator, text mining | PubMed |
| Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer. | Front Immunol | 2022 | 35990668 | PubTator, text mining | PubMed |
| Erythroid lineage-specific lentiviral RNAi vectors suitable for molecular functional studies and therapeutic applications. | Sci Rep | 2022 | 35982069 | PubTator, text mining | PubMed |
| ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators. | Front Oncol | 2022 | 35978821 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6708/papers?page=18